Compared with historical local cohorts of general NSCLC patients, ALK+ NSCLC patients were younger, more likely to be lifetime never-smokers and of Asian descent, with greater prevalence of pleural-pericardial disease, bone and brain metastases and presenting with some unusual patterns of metastatic spread. The gene discussed is ALK; the disease is non-small cell lung carcinoma.